SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001140361-23-003616
Filing Date
2023-01-31
Accepted
2023-02-01 08:53:09
Documents
4
Group Members
BIOSYNEX U.S. HOLDINGS, INC.PROJECT MERCI MERGER SUB, INC.

Document Format Files

Seq Description Document Type Size
1 SC TO-C ny20007172x1_sctoc.htm SC TO-C 20535
2 EXHIBIT 99.1 ny20007172x1_ex99-1.htm EX-99.1 32229
3 ny20007172x1_ex99-1img01.jpg GRAPHIC 4255
4 ny20007172x1_ex99-1img02.jpg GRAPHIC 6008
  Complete submission text file 0001140361-23-003616.txt   68940
Mailing Address 555 WIRELESS BLVD. HAUPPAUGE NY 11788
Business Address 555 WIRELESS BLVD. HAUPPAUGE NY 11788 (631) 924-1135
CHEMBIO DIAGNOSTICS, INC. (Subject) CIK: 0001092662 (see all company filings)

IRS No.: 880425691 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-61925 | Film No.: 23574857
SIC: 2834 Pharmaceutical Preparations

Mailing Address 22 BOULEVARD SEBASTIEN BRANT ILLKIRCH-GRAFFENSTADEN I0 67400
Business Address 22 BOULEVARD SEBASTIEN BRANT ILLKIRCH-GRAFFENSTADEN I0 67400 33(0)670860015
Biosynex SA (Filed by) CIK: 0001964166 (see all company filings)

IRS No.: 481075703 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC TO-C